Article Sidebar

PDF
Date Published: 25/03/2024
Abstract Views: 64
Views PDF: 38
DOI: https://doi.org/10.51298/vmj.v536i2.8871
Issue
Vol. 536 No. 2 (2024)
Section
Các bài báo
How to Cite
Nguyễn , T. T., & Đỗ , A. T. . (2024). RESULTS OF FIRST-STEP PACLITAXEL AND CARBOPLATIN CHEMOTHERAPY REGIMEN IN PATIENTS WITH STAGE IV ESOPHAGEAL CANCER AT K HOSPITAL. Vietnam Medical Journal, 536(2). https://doi.org/10.51298/vmj.v536i2.8871

RESULTS OF FIRST-STEP PACLITAXEL AND CARBOPLATIN CHEMOTHERAPY REGIMEN IN PATIENTS WITH STAGE IV ESOPHAGEAL CANCER AT K HOSPITAL

Thu Trang Nguyễn , Anh Tú Đỗ

Main Article Content

Abstract

Objective: Evaluating the results of first-step Paclitaxel and Carboplatin chemotherapy regimen in patients with stage IV esophageal cancer at K hospital. Methods: A retrospective and prospective descriptive study were conducted on 54 people with stage IV esophageal cancer from March 2023 to October 2023. Results: The rate of patients responding to treatment was 51.8% (partial response was 44.4% and complete response was 7.4%). Symptoms of choking, pain when swallowing, and choking improved after treatment. Common unwanted effects include nausea, vomiting, and hair loss. Hematological side effects have a low rate and can be controlled. Conclusion: This treatment regimen should be applied more commonly in the treatment of patients with stage IV esophageal cancer due to its safety and good tolerability.

Article Details

References

1. Sung, H., et al., Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 2021. 71(3): p. 209-249.
2. International Agency for Research on Cancer, VietNam - Global Cancer Observatory. 2020.
3. Keresztes, R.S., et al., Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: results of a phase II trial. The Journal of Thoracic and Cardiovascular Surgery, 2003. 126(5): p. 1603-1608.
4. de Man, F.M., et al., Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients. Cancers (Basel), 2019. 11(6).
5. Wang, H., et al., A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer. J Thorac Oncol, 2007. 2(2): p. 153-7.
6. Nguyễn Đức Lợi, Đánh giá hiệu quả của hóa xạ trị gia tốc đồng thời trong điều trị ung thư thực quản giai đoạn III, IV bệnh viện K. Tạp chí Y học Việt Nam, 2018. 471(Số chuyên đề ung thư): p. 48-55.
7. Noronha, V., et al., Clinical Outcome in Definitive Concurrent Chemoradiation With Weekly Paclitaxel and Carboplatin for Locally Advanced Esophageal and Junctional Cancer. Oncol Res, 2016. 23(4): p. 183-95.
8. Joseph, D.M., et al., Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study. South Asian J Cancer, 2021. 10(3): p. 151-154.